SKI Market

A+| A| A-|

Indian Indices

Sensex

74,649.84 382.50
( 0.52%)

Global Indices

Nasdaq

51,095.09 41.63
(0.08%)

Dow Jones

7,620.62 19.56
(0.26%)

Hang Seng

66,649.95 -284.38
(-0.42%)

Nikkei 225

10,376.42 37.47
(0.36%)

Forex

USD-INR

94.75 -1.18
(-1.23%)

EUR-INR

110.47 -1.07
(-0.96%)

GBP-INR

127.45 -1.26
(-0.98%)

JPY-INR

0.59 -0.01
(-1.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

13.04

16714.53

EPS(TTM)

Face Value()

Div & Yield %

71.55

0.54

Back

digispice technologies ltd

Indiabulls reports consolidated net profit of Rs 79.37 crore in the December 2025 quarter

Feb 02,2026

Net profit of Indiabulls reported to Rs 79.37 crore in the quarter ended December 2025 as against net loss of Rs 3.69 crore during the previous quarter ended December 2024. Sales declined 8.90% to Rs 96.96 crore in the quarter ended December 2025 as against Rs 106.43 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	96.96	106.43	-9
OPM %	-14.68	22.84	-
PBDT	-18.68	31.75	PL
PBT	-27.56	22.21	PL
NP	79.37	-3.69	LP

74,649.84 382.50 ( 0.52%)

51,095.09 41.63 (0.08%)

7,620.62 19.56 (0.26%)

66,649.95 -284.38 (-0.42%)

10,376.42 37.47 (0.36%)

94.75 -1.18 (-1.23%)

110.47 -1.07 (-0.96%)

127.45 -1.26 (-0.98%)

0.59 -0.01 (-1.17%)